Price: Check with seller

No image available

Description

Tucatinib 50 and 150 mg tablets, is transforming treatment for HER2-positive breast cancer, particularly when combined with trastuzumab and capecitabine. It targets HER2-positive cells, enhancing therapeutic outcomes and prolonging survival in advanced-stage patients, including those with brain metastases. The availability of Tucatinib 150 mg in India marks a significant step forward. Impomed Healthcare is the trusted provider for this vital treatment, enhancing access to advanced cancer care options. For more information visit:- https://www.impomedhealthcare.com/

More Details

Total Views:20
Reference Id:#2433641

Comments

Copyright © 2008 - 2024 |   All Rights Reserved |   tuffclassified.com |   24x7 support |   Email us : info[at]tuffclassified.com